Abstract:Background. Rapamycin is known to induce autophagy, promote cell survival and inhibit the progression of diabetic nephropathy (DN). Objectives. The aim of this study was to examine the role of autophagy in the treatment of DN with rapamycin to provide the basis for the DN treatment with rapamycin. Materials and methods. Human mesangial cells (HMC) were cultured in a constant temperature incubator with 5% CO2, at 37 degrees C and saturated humidity. Cells were divided into 5 groups and the 5-ethynyl2-deoxyuridine (EdU) cell proliferation assay was used to determine cell proliferation. Flow cytometry was used to determine cell apoptosis, while GFP-RFP-LC3 showed autophagy flow. Western blot was employed to detect the expression of autophagy-related proteins LC3-II/LC3-I and P62. Enzyme -linked immunosorbent assay (ELISA) was used to determine the contents of type IV collagen fiber (Col4), hyaluronic acid (HA) and laminin (LA) in the extracellular matrix (ECM). Results. Cell proliferation was the lowest in the hyperglycemic group. Additionally, the hyperglycemic group displayed the lowest number of autolysosomes compared to other groups. In contrast, the rapamycin group exhibited the highest number of autolysosomes. The LC3-II/LC3-I ratio was also the lowest in the hyperglycemic group, measuring 0.53 (0.50-0.58), while the expression level of P62 was significantly higher in that group at 0.98 (0.95-1.01) compared to other groups. Upon the introduction of rapamycin, the LC3-II/LC3-I ratio was significantly increased at 2.21 (1.95-2.21), and P62 was significantly decreased 0.38 (0.38-0.39) compared to the hyperglycemic group. Both changes were statistically significant, with p -values of 0.034 and 0.010, respectively. Enzyme -linked immunosorbent assay was employed to detect Col4, HA and LA content. The study findings demonstrated significantly higher levels of glucose in the hyperglycemic group in comparison to other groups. In contrast, the rapamycin group exhibited significantly lower levels of glucose than the hyperglycemic group, yet the difference was not statistically significant. Conclusions. Hyperglycemic can inhibit the autophagic activity of HMC, promote cell apoptosis, enhance ECM accumulation, and facilitate the DN progression. In contrast, rapamycin can elicit autophagy, decrease mesangial matrix proliferation, and therefore impede DN progression.

Rapamycin Enhances Repressed Autophagy and Attenuates Aggressive Progression in A Rat Model of Iga Nephropathy

Rapamycin Induces Autophagy and Reduces the Apoptosis of Podocytes under a Stimulated Condition of Immunoglobulin A Nephropathy

Rapamycin Reduces Podocyte Apoptosis and is Involved in Autophagy and Mtor/ P70S6K/4EBP1 Signaling.

Rapamycin prevents early steps of the development of diabetic nephropathy in rats.

Rapamycin Protects Against Aristolochic Acid Nephropathy in Mice by Potentiating Mammalian Target of Rapamycin-Mediated Autophagy

The Roles of Autophagy in the Treatment of Diabetic Nephropathy with Rapamycin

Rapamycin Ameliorates Experimental Autoimmune Uveoretinitis By Inhibiting Thl/Th2/Th17 Cells And Upregulating Cd4+Cd25+Foxp3 Regulatory T Cells

Metformin combined with rapamycin ameliorates podocyte injury in idiopathic membranous nephropathy through the AMPK/mTOR signaling pathway

Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin.

Rapamycin Induces Autophagy to Alleviate Acute Kidney Injury Following Cerebral Ischemia and Reperfusion Via the Mtorc1/atg13/ulk1 Signaling Pathway

Rapamycin ameliorates chronic intermittent hypoxia and sleep deprivation-induced renal damage via the mammalian target of rapamycin (mTOR)/NOD-like receptor protein 3 (NLRP3) signaling pathway

Autophagy activation attenuates renal ischemia-reperfusion injury in rats.

Rapamycin Attenuates Atrial Fibrosis in 5/6 Nephrectomized Rats by Inhibiting Mammalian Target of Rapamycin and Profibrotic Signaling

Rapamycin-induced autophagy protects proximal tubular renal cells against proteinuric damage through the transcriptional activation of the nerve growth factor receptor NGFR

Effects of Rapamycin on Nephropathy of Diabetic Rats and Expressions of Vascular Endothelial Growth Factor and Its Receptor

Effects of rapamycin on podocytes of rats with diabetic nephropathy

Rapamycin Ameliorates Kidney Fibrosis by Inhibiting the Activation of Mtor Signaling in Interstitial Macrophages and Myofibroblasts

Rapamycin improves insulin resistance and hepatic steatosis in type 2 diabetes rats through activation of autophagy.

Aged kidneys are refractory to autophagy activation in a rat model of renal ischemia-reperfusion injury.

Modulating autophagy improves cardiac function in a rat model of early-stage dilated cardiomyopathy.

Effects of Rapamycin on Nephropathy and Expression of VEGF and VEGF Receptors in PAN Nephritic Mice